18 Feb 2022 , 12:58 PM
Jagsonpal Pharmaceuticals Limited has entered into an agreement with Suvinys Developers Private Limited for the Supply of Product Dydrogesterone. Suvinys Developers will supply Dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
The company last week reported a total income of Rs56.4275 crore during the period ended December 31, 2021, as compared to Rs.57.6391 crore during the period ended December 31, 2020. It posted a net profit of Rs5.4065 crore for the period ended December 31, 2021, as against a net profit of Rs5.4303 crore for the period ended December 31, 2020.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
